UTHR
United Therapeutics CorporationNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$25.32B
P/E Ratio
20.75
EPS
$27.84
Beta
0.75
52W High
$607.89
52W Low
$272.12
50-Day MA
$514.65
200-Day MA
$434.19
Dividend Yield
—
Profit Margin
41.90%
Forward P/E
20.28
PEG Ratio
2.28
About United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Fundamentals
| Revenue (TTM) | $3.18B |
| Gross Profit (TTM) | $2.80B |
| EBITDA | $1.60B |
| Operating Margin | 45.00% |
| Return on Equity | 19.70% |
| Return on Assets | 12.40% |
| Revenue/Share (TTM) | $71.84 |
| Book Value | $162.60 |
| Price-to-Book | 3.53 |
| Price-to-Sales (TTM) | 7.95 |
| EV/Revenue | 6.89 |
| EV/EBITDA | 12.06 |
| Quarterly Earnings Growth (YoY) | 24.50% |
| Quarterly Revenue Growth (YoY) | 7.40% |
| Shares Outstanding | $43.83M |
| Float | $40.32M |
| % Insiders | 1.94% |
| % Institutions | 97.61% |
Historical Volatility
HV 10-Day
66.69%
HV 20-Day
49.55%
HV 30-Day
52.14%
HV 60-Day
47.56%
HV Rank
76.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($644.08 target)
1
Strong Buy9
Buy4
HoldData last updated: 4/14/2026